Tag

Column

All articles tagged with #column

GTA VI's hype machine thrives as Netflix-led rollout fuels leaks
column2 days ago

GTA VI's hype machine thrives as Netflix-led rollout fuels leaks

Rockstar’s Grand Theft Auto VI remains the industry’s biggest spectacle, riding a Netflix-timed gameplay reveal and a flood of leaks that have only amplified anticipation ahead of its November 19 launch. Despite legal skirmishes over leaks, past delays, and questions about physical media, the game’s scale and Rockstar’s marketing prowess are turning every development—official or not—into a marketing moment that could reshape the industry’s release dynamics.

Foldables mature and Apple could push them mainstream
column23 days ago

Foldables mature and Apple could push them mainstream

Foldable phones have shed their novelty and matured into durable, feature-rich devices across multiple brands, with thinner profiles and new form factors. As the tech reaches mainstream readiness, Apple is poised to launch a foldable iPhone which IDC says could capture a sizable share of the market in its first year. The big question is whether Apple’s influence and premium pricing will expand foldables beyond enthusiasts or keep them niche.

PMOS reveals the long road to truly personalized health
column3 months ago

PMOS reveals the long road to truly personalized health

Victoria Song argues that renaming PCOS to PMOS reflects a broader hormonal and metabolic condition, and that personalized health tech is not yet capable of reliably addressing chronic illnesses. While wearables and AI promise tailored guidance, PMOS manifests differently across individuals, interacts with insulin resistance and medications, and is influenced by factors like hormonal contraception, making universal personalization elusive. Despite industry optimism, real-world personalization still requires significant self-tracking, medical input, and trial-and-error, highlighting a gap between hype and what current science and healthcare systems can safely deliver.

Sacks loses sway as White House pivots to tighter AI oversight
column3 months ago

Sacks loses sway as White House pivots to tighter AI oversight

The Verge reports that the Trump White House reversed course on AI oversight—moving toward federal review of pre‑market AI models—after Anthropic’s Mythos raised national-security alarms, while David Sacks’s influence as AI/crypto czar waned and more agencies gained authority (CAISI/NIST) to test frontier AI; international regulatory pressure and geopolitical events underscore the shift toward tighter tech rules.

Proteinmaxxing: chasing gains in a wellness Wild West
column5 months ago

Proteinmaxxing: chasing gains in a wellness Wild West

Victoria Song’s Optimizer column critiques the wellness world’s obsession with protein, detailing trends like boy kibble, proteinmaxxing, and protein washing. While protein has real benefits for satiety and muscle health, influencers push extreme intake and “healthy” protein products, often with little nuance about total diet. The piece traces examples from Target aisles to protein bars and Pop-Tarts, discusses regulatory questions around labeling and safety, and concludes that a balanced diet with vegetables—not blanket high-protein obsession—is the smarter path.

Netflix’s Warner Bros. deal could push rivals toward bundles and consolidation
column6 months ago

Netflix’s Warner Bros. deal could push rivals toward bundles and consolidation

Netflix’s $82.7 billion acquisition of Warner Bros. Discovery is poised to reshape the streaming landscape, pressuring rivals like Paramount+, Disney+, Peacock, and Apple TV+ to respond with bundles, exclusive content, or consolidation, while regulators weigh antitrust concerns and potential price impacts; the move could tilt the balance in Netflix’s favor even as competition, ads, and sports rights continue to redefine the market.